These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor. Tajima A, Yamamoto K, Kozakai A, Okumura-Kitajima L, Mita Y, Kitano K, Jingu S, Nakaike S. Eur J Pharmacol; 2011 Mar 25; 655(1-3):99-107. PubMed ID: 21262219 [Abstract] [Full Text] [Related]
16. Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats. El Batsh MM, El Batch MM, Shafik NM, Younos IH. Eur J Pharmacol; 2015 Dec 15; 769():297-305. PubMed ID: 26607467 [Abstract] [Full Text] [Related]
17. Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene expressions responsible for insulin secretion in streptozotocin induced diabetic rats. Akarte AS, Srinivasan BP, Gandhi S, Sole S. Eur J Pharm Sci; 2012 Sep 29; 47(2):456-63. PubMed ID: 22800967 [Abstract] [Full Text] [Related]
18. The scientific evidence: vildagliptin and the benefits of islet enhancement. Mathieu C. Diabetes Obes Metab; 2009 May 29; 11 Suppl 2():9-17. PubMed ID: 19385979 [Abstract] [Full Text] [Related]